SR1375 for severe pneumonia not improving on antibiotics
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new drug called SR1375 for adults with severe community-acquired pneumonia (a lung infection) who are not improving with standard antibiotics. It may help reduce inflammation and speed up recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old.
- You have been in the hospital for pneumonia, received IV antibiotics for at least 3 days, but are not getting better.
- Your pneumonia affects several parts of your lung (seen on a CT scan) and you need oxygen or a breathing machine.
- You have at least one high-risk factor, such as COPD, diabetes, age 65+, or obesity.
- You are expected to stay in the hospital for at least 7 more days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial tests an investigational medicine called Trimodulin (BT588) for people with severe pneumonia who need a breathing machine. The goal is to see if it helps them recover faster.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial tests a drug called Polymyxin E2 Methanesulfonate for a serious lung infection that patients can get in the hospital, caused by bacteria that don't respond to common antibiotics. It may be an option for people on ventilators or recently hospitalized with pneumonia that standard drugs can't treat.
This trial tests whether adding an experimental herbal medicine (NRICM102) to standard antibiotics can help adults hospitalized with community-acquired pneumonia recover faster. It is a phase 2 study, meaning the treatment is still being tested for safety and effectiveness.
This trial tests a new medication called OPT101 for people hospitalized with pneumonia and sepsis (a severe infection that affects the whole body). The drug may help reduce inflammation and improve oxygen levels. The study focuses on those who need extra oxygen but are not yet on a breathing machine.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.